Lucerum Blog
Home > Blog
Looking for something specific?
Sleep, Vigilance, and Seizures
Sleep is a pharmacologically active brain state. The sleep-wake cycle continuously regulates cortical excitability, with NREM transitions elevating and REM suppressing seizure susceptibility. A 2025 meta-analysis now provides robust population-level evidence that sleep deprivation measurably reduces cortical inhibition. Many drugs in routine use — across addiction medicine, psychiatry, and pain management — alter the sleep architecture that maintains this inhibitory tone. For alcohol and GABAergic sedatives, the link from sleep disruption to withdrawal seizure is mechanistically direct. For antidepressants, stimulants, and opioids, the sleep-architecture pathway adds a layer of risk that warrants consideration alongside the drugs’ direct pharmacological effects.
The Third Eye That Went Dark: How an Ancient Light Sensor Became the Body’s Clock, Mood Regulator, and Inner Psychedelic
🧠 The Third Eye That Went Dark
Deep in your brain sits a pea-sized gland that once looked out at the sky. In fish, amphibians, and reptiles, the pineal is literally a light sensor — some lizards still have a rudimentary third eye on top of their skull. In us, it went blind. But it didn't stop reacting to light.
Every night, light hitting your retina takes a long detour from the brain down the spinal cord, and back up — just to tell one small gland: it's dark now. The pineal answers with melatonin, the signal that sets sleep, seasonal reproduction, autonomic tone, and the hand-off from "fight or flight" to "rest and digest."
When this timing loop drifts, mental health follows. In OCD, the clock runs late and quiet — delayed melatonin, smaller pineal glands on MRI. In bipolar disorder, it runs hypersensitive — nighttime light suppresses melatonin twice as much as in healthy controls, even in unaffected relatives.
And here's the twist most people miss: the pineal also produces trace amounts of DMT and pinoline — chemical cousins of the two active ingredients in ayahuasca. Whatever their natural role, their relatives are now delivering rapid antidepressant effects in clinical trials of treatment-resistant depression.
An ancient third eye, blinded but not silenced, still runs a surprising amount of the show.
#Neuroscience #MentalHealth #Chronobiology #Psychedelics #Melatonin
Personalizing TMS with qEEG guidance: Two Ways to Stop Guessing Where to Stimulate
Most TMS treatments still place the coil based on scalp landmarks — a pragmatic approach that has served the field well but leaves significant individual variability unaddressed. We now have better tools. Two data sources generate from EEG can tell you precisely where to aim and what to do when you get there: current source density (CSD) from qEEG and functional connectivity maps. Here's how each works, and how to combine them and where to find the precision tools needed for personalized TMS.
When the Brain Speaks Without Words: Decoding Tacit Knowledge and Intelligence Through Neural Connectivity
In neuroscience and cognitive science, we are often taught that what matters is what can be measured. But some forms of human expertise—like intuition, skill, or insight—have long eluded direct observation. We call this tacit knowledge: knowing how to act, without necessarily being able to say why.
Neuroanalytics: Cutting Through the Hype and Misunderstandings
The allure of neuroanalytics is undeniable. The ability to measure, map, and analyze brain activity has sparked excitement across fields ranging from medicine and psychology to marketing and education. Promises abound: personalized mental health treatments, brain-computer interfaces, real-time performance optimization, and even unlocking the secrets of creativity. But with great promise often comes great hype—and neuroanalytics is no exception.